Beta-Cryptoxanthin Osteogenesis Promotion via Bone Mineral Density
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoporosis primarily focus on inhibiting bone resorption rather than promoting osteogenesis, and existing osteogenesis promoters have limited effectiveness in increasing bone mass and density.
Innovation Solution
The use of β-cryptoxanthin, a carotenoid found in Satsuma oranges, as an active ingredient to promote osteogenesis and inhibit bone resorption, thereby preventing and treating osteoporosis by accelerating bone calcification and increasing bone mineral density.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional osteoporosis treatments focusing on inhibiting bone resorption are used, then bone resorption is reduced, but bone mass increase is limited and osteogenesis promotion is insufficient
Solution Approach 1:
The patent introduces a novel therapeutic parameter by using β-cryptoxanthin, a carotenoid compound, which changes the approach from单纯的骨吸收抑制 to同时促进骨形成。This substance activates osteoblast differentiation and bone formation pathways, providing a new mechanism that complements existing anti-resorption treatments and addresses the limitation of insufficient osteogenesis promotion.
2Productivity
If existing osteogenesis promoters are used, then some bone formation stimulation is achieved, but effectiveness in increasing bone mass and density is limited
Solution Approach 1:
The patent combines β-cryptoxanthin with calcium and vitamin D to create a composite formulation that synergistically enhances osteogenesis. This composite approach leverages the osteoblast-differentiating effect of β-cryptoxanthin alongside the bone-mineralizing properties of calcium and vitamin D, achieving superior bone mass and density increases compared to single-agent osteogenesis promoters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
β-cryptoxanthin significantly increases bone calcium levels, alkaline phosphatase activity, and DNA content in bone tissue, effectively promoting osteogenesis and inhibiting bone resorption, making it a potent anti-osteoporotic factor.
Implementation Method 1
accelerating bone calcification and increasing bone mineral density
Data Source
AI summary
It is intended to provide an osteogenesis promoter having a remarkable effect of positively promoting osteogenesis and thus preventing/treating bone diseases; a preventive/a remedy for bone diseases such as osteoporosis having both of an osteogenesis-promoting effect and a bone resorption-inhibiting effect; and a method of screening an active ingredient for preventing/treating bone diseases by using a compound having both of an osteogenesis-promoting effect and a bone resorption-inhibiting effect as a lead compound. It is confirmed that beta-cryptoxanthin, which occurs in a large amount in peel and sarcocarp of satsuma orange, has an osteogenesis-promoting effect and a therapeutic effect on bone disease. Thus, beta-cryptoxanthin or its composition is used as an osteogenesis promoter, a preventive/a remedy for bone diseases, a functional food or a food material for preventing/treating bone diseases and a feed composition.